Delivery formulations

Bristol Myers Squibb, Noxopharm to partner on immunotherapy pilot

23-Nov-2020 By Jenni Spinner

The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidate’s potential in overcoming resistance of a cancer drug.

Minakem: CM reaps time-saving, quality-boosting benefits

04-Nov-2020 By Jenni Spinner

Leaders from the CDMO discuss how the surging interest in continuous manufacturing can result in cost savings and numerous other advantages.

TFF Pharmaceuticals partners with Experic to expand manufacturing

26-Oct-2020 By Jenni Spinner

The clinical-stage pharma firm will install a processing line at Experic’s cGMP facility in New Jersey to handle its thin-film freezing technology.

Premier Research: holistic approach benefits drug development

06-Oct-2020 By Jenni Spinner

A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.

IntelGenx, ATAI partner on film-based psychedelics

03-Sep-2020 By Jenni Spinner

The companies will join forces to use IntelGenx’s polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments.

TFF, Union Therapeutics join on potential COVID-19 treatment

27-Aug-2020 By Jenni Spinner

The companies will partner on developing dry-powder forms of niclosamide as a treatment for the virus, using thin-film freezing technology.

Colorcon invests in AI-centric drug discovery

24-Aug-2020 By Jenni Spinner

The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery

Healx collaborates on Angelman syndrome therapies

19-Aug-2020 By Jenni Spinner

The AI-centric drug discovery technology firm is working with a foundation to discover potential treatments for the rare neurogenetic disorder.

Biorasi: precision medicine trials call for specialized approach

19-Aug-2020 By Jenni Spinner

A leader from the speed-focused CRO talks about the specialized needs of precision medicine trials, and how sites and sponsors can succeed on such studies.

People on the Move: August 2020

04-Aug-2020 By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

Absorption Systems: complex generics offer obstacles, opportunities

21-Jul-2020 By Jenni Spinner

A leader from the CRO shares perspectives on the challenges and rewards associated with the category, and approaches in getting generics to market.

A-Alpha Bio lands Gates Foundation drug development grant

13-Jul-2020 By Jenni Spinner

The $800K grant will fund development of therapeutics for infectious diseases, including respiratory viruses like COVID-19, using machine learning.

G1 Therapeutics: trilaciclib shows benefits for lung cancer patients

14-May-2020 By Jenni Spinner

The company will present data from recent Phase 2 trials of the investigational drug at the upcoming ASCO20 virtual conference on May 29.

3M Drug Delivery Systems relaunches as Kindeva Drug Delivery

04-May-2020 By Jenni Spinner

The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners.

Saama launches COVID-19 data collaboration

06-Apr-2020 By Jenni Spinner

The company’s EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus.